These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7494341)

  • 1. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.
    Srinivas SK; Sixbey JW
    J Virol; 1995 Dec; 69(12):8155-8. PubMed ID: 7494341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L; Perricaudet M; Sergeant A; Manet E
    J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X; Yalamanchili R; Harada S; Kieff E
    J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
    Jansson A; Masucci M; Rymo L
    J Virol; 1992 Jan; 66(1):62-9. PubMed ID: 1370095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
    Robertson ES; Lin J; Kieff E
    J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
    Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA; Sugden B
    J Virol; 1993 Nov; 67(11):6379-86. PubMed ID: 8411339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
    Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ; Jacquemin MG; Farrell PJ
    Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
    Robertson KD; Barletta J; Samid D; Ambinder RF
    Curr Top Microbiol Immunol; 1995; 194():145-54. PubMed ID: 7534666
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
    Marchini A; Longnecker R; Kieff E
    J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
    Horvath GC; Schubach WH
    Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.